A new paradigm in therapeutic development is emerging as Remepy, a pioneering startup, successfully completed a Phase IIa clinical trial…
Read More

A new paradigm in therapeutic development is emerging as Remepy, a pioneering startup, successfully completed a Phase IIa clinical trial…
Read More
A new era in therapeutic innovation is dawning, marked by the successful Phase IIa clinical trial results for Hybridopa, an…
Read More
In a significant advancement for integrated medicine, Remepy, a pioneering startup, has announced successful Phase IIa clinical trial results for…
Read More
A significant stride in the realm of integrated medicine has been reported by Remepy, a pioneering startup, as its innovative…
Read More
In a significant advancement for integrated medicine, Remepy, a pioneering startup, has announced successful Phase IIa clinical trial results for…
Read More
Immuto Scientific, a trailblazing company co-founded in 2018 by CEO Faraz A. Choudhury, Ph.D., and CTO Daniel Benjamin, Ph.D., both…
Read More
Immuto Scientific, a pioneering biotechnology firm co-founded in 2018 by electrical engineers Faraz A. Choudhury, Ph.D. (CEO), and Daniel Benjamin,…
Read More
Immuto Scientific, a trailblazing company co-founded in 2018 by electrical engineers Faraz A. Choudhury, Ph.D. (CEO) and Daniel Benjamin, Ph.D.…
Read More
In a significant development poised to accelerate drug discovery, Immuto Scientific, a biotech firm co-founded in 2018 by CEO Faraz…
Read More
Immuto Scientific, a pioneering company co-founded in 2018 by electrical engineers Dr. Faraz A. Choudhury (CEO) and Dr. Daniel Benjamin…
Read More